BioScreen Testing Services

What BioScreen Testing Services does

BioScreen Testing Services, Inc. is a contract testing laboratory founded in 1985 and based in Torrance, California, providing analytical chemistry, clinical, microbiology, stability, and toxicology testing services. Its core service portfolio includes quantitative and qualitative chemical analysis, clinical laboratory testing supporting pharmaceutical and healthcare needs, microbiological assessment of biological contamination and sterility, stability studies to determine shelf life and storage conditions, and toxicological analysis for safety assessment and regulatory compliance. The company serves regulated-industry clients — primarily in pharmaceutical and healthcare — that require credentialed laboratory testing across these disciplines.

Since February 2019, BioScreen has operated as a wholly-owned subsidiary of ALS (ALS Limited), a publicly listed global testing services company, following its acquisition. Post-acquisition, BioScreen locations continue to deliver their specialized testing services under the ALS umbrella, with prospective clients directed to the ALS website for the full suite of environmental, food safety, pharmaceutical, and materials testing. The BioSecure client portal (biosecure.bioscreen.com) functions as the primary client-facing interface, providing online sample tracking, analytical results delivery, and testing management.

Business model and revenue mechanics are not publicly disclosed: pricing is not listed, customer segments are described only at a use-case level, and no named customer logos or contract values are present in the source data. BioScreen's go-to-market is now executed through ALS's global marketing and distribution infrastructure rather than via an independent commercial motion, and its competitive positioning rests on integrated laboratory capabilities across chemistry, clinical, microbiology, stability, and toxicology rather than a modular product lineup.

Name

BioScreen Testing Services

Legal name

BioScreen Testing Services, Inc.

Website

https://bioscreen.com

Company type

Private

Founded year

1985

Operating status

Acquired

Headcount range

101–250 employees

Short description

BioScreen Testing Services is a Torrance, California-based contract testing laboratory founded in 1985 that provides analytical chemistry, clinical, microbiology, stability, and toxicology testing services to pharmaceutical and healthcare clients, operating as a wholly-owned subsidiary of ALS since February 2019.

Ownership category

akta.pro rank

Product category

Contract Laboratory Testing Services

NAICS

Testing Laboratories and Services (541380), Medical Laboratories (621511)

SIC

Services-Testing Laboratories (8734), Services-Medical Laboratories (8071), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Analytical Development & QC Testing (Release/Stability/Potency) (HLAGAGAF)

akta.pro secondary industries

Microbiology & Infectious Disease Testing (Trial Support) (HLAGAEAF), Environmental Monitoring & Cleanroom Testing (GMP) (HLAGADAL)

Keywords

• Analytical chemistry testing
• Microbiology laboratory services
• Stability testing services
• Toxicology testing services
• Clinical laboratory testing

Headquarters

HQ city

Torrance

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D

Core offering

BioScreen Testing Services is a contract testing laboratory providing analytical chemistry, clinical, microbiology, stability, and toxicology testing services. The company operates as part of the ALS global testing network following its acquisition in February 2019, serving clients across pharmaceutical, healthcare, cosmetics, and other regulated industries requiring laboratory testing and safety assessment.

Product overview

BioScreen Testing Services, Inc. (acquired by ALS in February 2019) is a testing laboratory offering a unified portfolio of analytical chemistry, clinical, microbiology, stability, and toxicology testing services. The company operates under the ALS corporate umbrella while maintaining its BioSecure client portal for sample and result management. The individual testing services function as integrated laboratory capabilities rather than modular products, with the BioSecure portal serving as the primary client-facing interface for accessing testing results and managing samples.

Differentiator

Problem solved

Functional benefit

Products and services

• Analytical Chemistry Testing Laboratory analytical chemistry testing services for various sample types, providing quantitative and qualitative chemical analysis for clients in pharmaceutical, healthcare, and regulated industries.
• Clinical Testing Clinical laboratory testing services supporting pharmaceutical and healthcare analytical needs.
• Microbiology Testing Microbiological testing services for assessing biological contamination, sterility, and microbial quality for clients requiring quality and safety testing.
• Stability Testing Stability studies and testing services to determine product shelf life and storage conditions, primarily for pharmaceutical and consumer product clients.
• Toxicology Testing Toxicological analysis services for safety assessment and regulatory compliance across pharmaceutical, cosmetic, and consumer product sectors.
• BioSecure Portal Online customer portal providing access to sample tracking, analytical results, and testing management capabilities for BioScreen clients.

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

One partnership is on record.

• ALS (formerly ALS Global)coreOthers · 1 February 2019BioScreen Testing Services, Inc. was acquired by ALS in February 2019. Following the acquisition, BioScreen locations continue to provide analytical chemistry, clinical, microbiology, stability and toxicology testing services as part of the ALS organization. BioScreen now operates under the ALS brand and redirects users to the ALS website for the full range of services.

Recent moves4 records

Expansion highlights4 records

Broad incumbents

• SGS: Global testing, inspection, and certification company with a significant life sciences and pharmaceutical testing division. Provides the same analytical chemistry, microbiology, and stability testing capabilities as BioScreen, at a substantially larger global scale.
• Eurofins Scientific: Global leader in bioanalytical, pharmaceutical, and food/environmental testing services with thousands of laboratories worldwide. Directly comparable to BioScreen as a contract testing laboratory serving pharma, food, and environmental end markets, though materially larger and broader in scope.
• Bureau Veritas: Global testing, inspection, and certification company with commodities, marine, and consumer product testing lines. Comparable as a fellow global TIC competitor with overlapping analytical and lab services in pharma-adjacent markets.
• Intertek: Global TIC (testing, inspection, certification) provider with a pharmaceutical services arm offering analytical and stability testing. Comparable to BioScreen's testing services for regulated industries, though operating across many additional end markets.
• Labcorp Drug Development: Major clinical and bioanalytical laboratory network providing pharmaceutical testing, central lab, and diagnostic services. Comparable testing capabilities to BioScreen, particularly in clinical and bioanalytical work supporting pharma clients.

Direct peers

• ICON plc: Global CRO providing clinical and bioanalytical laboratory services supporting pharmaceutical trials, including central lab and biomarker testing. Comparable as a testing-services partner for pharma sponsors, though heavier on clinical trial endpoints.
• WuXi AppTec: Contract research and testing organization providing analytical chemistry, stability, microbiology, and toxicology testing for pharmaceutical and biotech clients. Highly comparable service mix to BioScreen, with global scale and a strong biologics testing franchise.
• Catalent: Pharmaceutical services company offering analytical, stability, and microbiology testing alongside development and manufacturing. Highly comparable testing services to BioScreen within a broader CDMO business model.
• Pharmaron: Contract research organization offering analytical chemistry, formulation, stability, and safety/toxicology services to pharma and biotech clients. Closely comparable in discipline mix and pharma client focus, with larger global lab footprint.
• Charles River Laboratories: Major CRO offering analytical chemistry, microbiology, stability, and toxicology testing services to pharmaceutical and biotechnology clients. Closely comparable service-line mix to BioScreen in the pharma testing space, though serving a larger and more diversified client base.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights5 records

Customer concentration

• YouTubeyoutube.com/channel/UC9GTzaPtpqJYG7Gzdc7bygw
• LinkedInlinkedin.com/company/bioscreen-testing-services

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BioScreen Testing Services